Airway Epithelial MiRNA Expression is Altered in Asthma
Overview
Authors
Affiliations
Rationale: Changes in airway epithelial cell differentiation, driven in part by IL-13, are important in asthma. Micro-RNAs (miRNAs) regulate cell differentiation in many systems and could contribute to epithelial abnormalities in asthma.
Objectives: To determine whether airway epithelial miRNA expression is altered in asthma and identify IL-13-regulated miRNAs.
Methods: We used miRNA microarrays to analyze bronchial epithelial brushings from 16 steroid-naive subjects with asthma before and after inhaled corticosteroids, 19 steroid-using subjects with asthma, and 12 healthy control subjects, and the effects of IL-13 and corticosteroids on cultured bronchial epithelial cells. We used quantitative polymerase chain reaction to confirm selected microarray results.
Measurements And Main Results: Most (12 of 16) steroid-naive subjects with asthma had a markedly abnormal pattern of bronchial epithelial miRNA expression by microarray analysis. Compared with control subjects, 217 miRNAs were differentially expressed in steroid-naive subjects with asthma and 200 in steroid-using subjects with asthma (false discovery rate < 0.05). Treatment with inhaled corticosteroids had modest effects on miRNA expression in steroid-naive asthma, inducing a statistically significant (false discovery rate < 0.05) change for only nine miRNAs. qPCR analysis confirmed differential expression of 22 miRNAs that were highly differentially expressed by microarrays. IL-13 stimulation recapitulated changes in many differentially expressed miRNAs, including four members of the miR-34/449 family, and these changes in miR-34/449 family members were resistant to corticosteroids.
Conclusions: Dramatic alterations of airway epithelial cell miRNA levels are a common feature of asthma. These alterations are only modestly corrected by inhaled corticosteroids. IL-13 effects may account for some of these alterations, including repression of miR-34/449 family members that have established roles in airway epithelial cell differentiation. Clinical trial registered with www.clinicaltrials.gov (NCT 00595153).
Kierbiedz-Guzik N, Sozanska B Int J Mol Sci. 2025; 26(1.
PMID: 39795977 PMC: 11720134. DOI: 10.3390/ijms26010120.
MicroRNA Profiling of the Inflammatory Response after Early and Late Asthmatic Reaction.
Duecker R, Alemdar O, Wimmers A, Gronau L, Chiocchetti A, Valesky E Int J Mol Sci. 2024; 25(2).
PMID: 38279356 PMC: 10817008. DOI: 10.3390/ijms25021356.
Rynne J, Ortiz-Zapater E, Bagley D, Zanin O, Doherty G, Kanabar V Front Cell Dev Biol. 2023; 11:1241008.
PMID: 37928904 PMC: 10624177. DOI: 10.3389/fcell.2023.1241008.
miR-223: a key regulator of pulmonary inflammation.
Shi M, Lu Q, Zhao Y, Ding Z, Yu S, Li J Front Med (Lausanne). 2023; 10:1187557.
PMID: 37465640 PMC: 10350674. DOI: 10.3389/fmed.2023.1187557.
Zhu Z, Freishtat R, Harmon B, Hahn A, Teach S, Perez-Losada M Eur Respir J. 2023; 62(2).
PMID: 37321621 PMC: 10578345. DOI: 10.1183/13993003.00502-2023.